|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance of $7,647 and $6,294 as of December 31, 2025 and 2024, respectively | ||||||||||||||||||||
| Notes receivable | ||||||||||||||||||||
| Accounts receivable, net of allowance of $7,884 and $7,647 as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Investments – Equity Securities | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Right-of-use assets - operating | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Inventory, net of current portion | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Deficit | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Short-term debt - unaffiliated (includes debt measured at fair value of $3,695 at September 30, 2024 and $17,223 at December 31, 2023, respectively) | ||||||||||||||||||||
| Short-term debt - related parties | ||||||||||||||||||||
| Accrued R&D software | ||||||||||||||||||||
| Common stock to be issued | ||||||||||||||||||||
| Acquisition-related contingent consideration | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total short-term debt | ||||||||||||||||||||
| Other short-term debt | ||||||||||||||||||||
| Short-term debt - related party | ||||||||||||||||||||
| Short-term licensing obligation | ||||||||||||||||||||
| Short-term license obligation | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Preferred stock redemption liability | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred revenue, net of current portion | ||||||||||||||||||||
| Acquisition-related contingent consideration, net of current portion | ||||||||||||||||||||
| Noncurrent debt - related parties | ||||||||||||||||||||
| Noncurrent acquisition - related contingent consideration | ||||||||||||||||||||
| Noncurrent lease liabilities - operating | ||||||||||||||||||||
| Noncurrent accrued R&D software | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Long-term licensing obligation | ||||||||||||||||||||
| Long-term license obligation | ||||||||||||||||||||
| Deferred income tax liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity (deficit) | ||||||||||||||||||||
| Common Stock, $0.0001 par value, 730,000,000 shares authorized; 29,283,614 and 28,837,787 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Total liabilities and stockholders’ deficit | ||||||||||||||||||||
Loading...
